Johnson & Johnson pauses Covid vaccine trial as participant becomes ill
Johnson & Johnson said Monday it had temporarily halted its COVID-19 vaccine trial because one of its participants had become sick.
Oct 13, 2020
0
3
Johnson & Johnson said Monday it had temporarily halted its COVID-19 vaccine trial because one of its participants had become sick.
Oct 13, 2020
0
3
China, which has at least four coronavirus vaccine candidates in the last stage of clinical trials, said Friday it is joining an international initiative to distribute COVID-19 vaccines to countries worldwide known as COVAX, ...
Oct 9, 2020
0
3
Swiss authorities said Tuesday they had begun assessing AstraZeneca and Oxford University's COVID-19 vaccine—the first such treatment submitted for authorisation in the country.
Oct 6, 2020
0
5
The White House has blocked new Food and Drug Administration guidelines on bringing potential vaccines for COVID-19 to market that would almost certainly have prevented their approval before the Nov. 3 election.
Oct 6, 2020
0
2
The grim milestone of one million COVID-19 deaths should spur the planet into fighting back against the disease, the WHO insisted Tuesday, saying it was "never too late to turn things around".
Sep 29, 2020
0
0
Canadian Prime Minister Justin Trudeau announced Friday a deal with AstraZeneca to procure up to 20 million doses of its COVID-19 vaccine candidate being developed with Oxford University.
Sep 25, 2020
0
3
French pharmaceutical firm Sanofi and Britain's GSK have promised up to 72 million doses of their COVID-19 vaccine candidate to the Canadian government, which has already signed similar agreements with several American companies.
Sep 22, 2020
0
2
New research suggests that the impact of natural and vaccine-induced immunity will be key factors in shaping the future trajectory of the global coronavirus pandemic, known as COVID-19. In particular, a vaccine capable of ...
Sep 21, 2020
0
53
A China-developed coronavirus vaccine could be ready for the public as early as November, a Chinese official has told state television, as the global race to clear the final round of trials heats up.
Sep 15, 2020
0
91
Late-stage studies of AstraZeneca's COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient's "potentially unexplained" illness is a side effect of the shot.
Sep 9, 2020
0
34